Información*
| Nombre | ARISAI MARTINEZ MARTINEZ |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | FARMACOLOGÍA |
| Especialidad | OTRAS |
| CVU | 627661 |
| Institución | |
|---|---|
| Dependencia | UNIDAD ACADEMICA MULTIDISCIPLINARIA REYNOSA AZTLAN |
| Entidad | TAMAULIPAS |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2026 |
| Fin: 31/12/2030 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2025
- Chronic treatment with carboplatin induces mechanical hypersensitivity and neurochemical changes in the mouse dorsal root ganglia and spinal cord Cancer Chemotherapy and Pharmacology
- Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis mouse model Annals of the Rheumatic Diseases
- 2024
- Sex-dependent effects of the targeted nerve growth factor mutation (R100E) on pain behavior, joint inflammation, and bone erosion in mice. Pain
- 2023
- Insights into FcγR involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibody. Brain, behavior, and immunity
- 2022
- Characterization of pain-related behaviors, changes in bone microarchitecture and sensory innervation induced by chronic cadmium exposure in adult mice. Neurotoxicology
- 2021
- Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization. Pain
- 2020
- Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models. Pharmacological reports : PR
- Characterization of Mechanical Allodynia and Skin Innervation in a Mouse Model of Type-2 Diabetes Induced by Cafeteria-Style Diet and Low-Doses of Streptozotocin. Frontiers in pharmacology
- 2019
- Chronic administration of Cl-amidine, a pan-peptidylarginine deiminase inhibitor, does not reverse bone loss in two different murine models of osteoporosis. Drug development research
- 2017
- Repeated administration of mazindol reduces spontaneous pain-related behaviors without modifying bone density and microarchitecture in a mouse model of complete Freund's adjuvant-induced knee arthritis. Journal of pain research
